HK1257705A1 - Mvd作为用於鉴定免疫细胞特别是cd56+ nk细胞的表观遗传标志物 - Google Patents

Mvd作为用於鉴定免疫细胞特别是cd56+ nk细胞的表观遗传标志物 Download PDF

Info

Publication number
HK1257705A1
HK1257705A1 HK19100073.9A HK19100073A HK1257705A1 HK 1257705 A1 HK1257705 A1 HK 1257705A1 HK 19100073 A HK19100073 A HK 19100073A HK 1257705 A1 HK1257705 A1 HK 1257705A1
Authority
HK
Hong Kong
Prior art keywords
cells
mvd
identification
cell
epigenetic marker
Prior art date
Application number
HK19100073.9A
Other languages
English (en)
Chinese (zh)
Inventor
Sven Olek
Original Assignee
Epiontis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epiontis Gmbh filed Critical Epiontis Gmbh
Publication of HK1257705A1 publication Critical patent/HK1257705A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK19100073.9A 2015-09-25 2016-09-22 Mvd作为用於鉴定免疫细胞特别是cd56+ nk细胞的表观遗传标志物 HK1257705A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1516971.7A GB201516971D0 (en) 2015-09-25 2015-09-25 MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
GB1516971.7 2015-09-25
PCT/EP2016/072522 WO2017050882A1 (en) 2015-09-25 2016-09-22 Mvd as epigenetic marker for the identification of immune cells, in particular cd56+ nk cells

Publications (1)

Publication Number Publication Date
HK1257705A1 true HK1257705A1 (zh) 2019-10-25

Family

ID=54544101

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19100073.9A HK1257705A1 (zh) 2015-09-25 2016-09-22 Mvd作为用於鉴定免疫细胞特别是cd56+ nk细胞的表观遗传标志物

Country Status (8)

Country Link
US (1) US11788141B2 (OSRAM)
EP (1) EP3353321B1 (OSRAM)
JP (1) JP2018534910A (OSRAM)
CN (1) CN108026577B (OSRAM)
CA (1) CA2995350A1 (OSRAM)
GB (1) GB201516971D0 (OSRAM)
HK (1) HK1257705A1 (OSRAM)
WO (1) WO2017050882A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017125013B4 (de) * 2017-10-25 2019-10-17 Epiontis Gmbh MCC als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere basophiler Granulozyten
DE102018112644B4 (de) 2018-05-25 2020-06-10 Epiontis Gmbh CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen
DE102018116353B4 (de) * 2018-07-05 2020-06-10 Epiontis Gmbh Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening
CN119372341B (zh) * 2024-12-30 2025-04-11 北京致谱医学检验实验室有限公司 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH2220H1 (en) * 2001-08-10 2008-07-01 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
US20070243161A1 (en) * 2006-02-28 2007-10-18 Sven Olek Epigenetic modification of the loci for CAMTA1 and/or FOXP3 as a marker for cancer treatment
EP2878680B1 (en) * 2008-07-09 2016-06-08 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
PL2248913T3 (pl) * 2009-04-28 2017-04-28 Epiontis Gmbh GNLY jako marker epigenetyczny do identyfikacji komórek naturalnej cytotoksyczności ekspresjonujących CD56
CN102343086A (zh) * 2010-05-28 2012-02-08 四川大学 治疗或预防肿瘤的药物、肿瘤全细胞疫苗及其制备方法和用途
JP6010037B2 (ja) * 2010-10-08 2016-10-19 エピオンティス ゲーエムベーハー 腫瘍浸潤全ｔリンパ球の分析に基づいて、がん患者の生存指標を測定する方法
GB201112586D0 (en) 2011-07-22 2011-09-07 Epiontis Gmbh Epigenetic marker for the identification of natural killer cells
WO2013033627A2 (en) * 2011-09-01 2013-03-07 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics

Also Published As

Publication number Publication date
EP3353321B1 (en) 2020-11-04
WO2017050882A1 (en) 2017-03-30
CN108026577A (zh) 2018-05-11
GB201516971D0 (en) 2015-11-11
JP2018534910A (ja) 2018-11-29
CN108026577B (zh) 2022-09-23
US20180237855A1 (en) 2018-08-23
US11788141B2 (en) 2023-10-17
EP3353321A1 (en) 2018-08-01
CA2995350A1 (en) 2017-03-30

Similar Documents

Publication Publication Date Title
EP4397774A3 (en) Methods for barcoding nucleic acid molecules from individual cells or cell populations
WO2015200893A3 (en) Methods of analyzing nucleic acids from individual cells or cell populations
EP4241882A3 (en) Methods for sample preparation and analysis
HK1257122A1 (zh) Lrp5作为用於鉴定免疫细胞特别是b细胞的表观遗传标志物
EP4663768A3 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
WO2015112352A3 (en) Method and system for microbiome analysis
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2012051208A3 (en) Identifying rearrangements in a sequenced genome
NZ601079A (en) Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
WO2014117021A3 (en) Methods, compositions, kits, and systems for selective enrichment of target cells
EP4574993A3 (en) Methods and processes for non-invasive assessment of genetic variations
EP2752245A3 (en) System Or Method Of Including Analytical Units
WO2013107459A3 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
WO2014065889A3 (en) Multiplexed method for diagnosing classical hodgkin lymphoma
EP4498086A3 (en) Kit or device and method for detecting dementia
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2012139047A3 (en) Identifying and enumerating early granulated cells (egcs)
HK1219534A1 (zh) 分析仪器系统
WO2016127077A8 (en) Systems and methods for detection and analysis of biological species
BR112012024206B8 (pt) método de detecção de células difíceis de remover hemoglobina, e método automático de quantificar células difíceis de remover hemoglobina
MX2015001961A (es) Metodos y sistemas para ensayos.
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
WO2013126807A3 (en) Simultaneous acquisition of biometric data and nucleic acid
WO2013177121A3 (en) Identification and quantification of intact glycopeptides in complex samples
WO2009017879A3 (en) Image portion identification methods, image parsing methods, image parsing systems, and articles of manufacture